FIG 7.
Observed (points) and PD model simulations (lines) of the individual pretomanid plasma concentration, CFU, and TTP profiles for the first five participants in the 150-mg dose group of the CL-010 study.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.